The Rest Of Europe Veterinary Reference Laboratory Market was valued at $72.08 Million in 2025 and projected to reach to $89.76 Million by 2030, representing a compound annual growth rate of 4.5%. Rest Of Europe's veterinary reference laboratory market demonstrates moderate but consistent growth potential, driven by increasing pet healthcare expenditure and expanding diagnostic capabilities across the region.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Rest Of Europe's veterinary reference laboratory market is valued at USD 72.08 million in 2025, with projected growth to USD 89.76 million by 2030, reflecting a steady CAGR of 4.5%.
The region encompasses diverse veterinary healthcare systems with varying levels of diagnostic infrastructure, creating fragmented market dynamics and localized service provider opportunities across different countries.
Increasing pet ownership, rising awareness of animal health diagnostics, and modernization of veterinary facilities in emerging European markets are driving demand for reference laboratory services.
Regulatory fragmentation across Rest Of Europe countries, limited laboratory standardization, and competition from established regional players present barriers to market expansion and service consolidation.
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | OTHER COMPANION ANIMALS (Type) |
| Forecast Period | 2025–2030 |
| Growth Rate | CAGR of 6.3% from 2025 to 2030 |
| Largest Segment | VETERINARY CLINICS & HOSPITALS (End User) |
| Market Size Base Year (Billions) | ~USD 4.75 (2025) |
| Revenue Forecast (Billions) | ~USD 6.45 (2030) |
| Segments Covered | Service, Animal Type, Application, Type, End User |
5 segment dimensions are covered across the global market.
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| ABAXIS INC | United States | Private Company | Veterinary analyzers & consumables (VetScan, hematology, rapid tests),Human point-of-care chemistry (Piccolo analyzers and profiles),OEM/technology licensing and other (Orbos lyophilization, i-STAT related), |
| IDEXX LABORATORIES, INC. | United States | Public Company | Companion Animal Group (in-clinic analyzers, SNAP assays, reference labs, telemedicine, software),Water Quality Products,Livestock, Poultry and Dairy (including human diagnostic products), |
| CVS (UK) LIMITED | United States | Public Company | Health Care Benefits,Health Services (PBM and related),Pharmacy & Consumer Wellness, |
| NATIONAL VETERINARY SERVICES LABORATORY USDA-APHIS | United States | U.S. Federal Government | Regulatory and confirmatory diagnostics,Reference methods, standards, and proficiency testing,Research, assay development, and validation services, |
| PRIVATE VETERINARY CLINIC SAN MARCO SRL UNIPERSONALE | Italy | Private Company | Advanced clinical care (surgery, hospitalization, critical care),Diagnostics and imaging,Preventive and routine care, |
ABAXIS INC is a private company founded in 1989 in the United States with 656 employees.
IDEXX Laboratories, Inc. is a public company founded in 1983 in the United States with 11,000 employees.
CVS (UK) Limited is a public company founded in 1963 in the United States with 259,500 employees.
National Veterinary Services Laboratory USDA-APHIS is a U.S. federal government laboratory founded in 1961.
Private Veterinary Clinic San Marco SRL Unipersonale is a private company based in Italy.
Rest Of Europe's veterinary reference laboratory market is valued at USD 72.08 million in 2025.
Rest Of Europe's veterinary reference laboratory market is forecast to reach USD 89.76 million by 2030.
Rest Of Europe's veterinary reference laboratory market is expected to grow at a CAGR of 4.5% from 2025 to 2030.
Rest Of Europe's market growth is driven by increasing pet ownership, rising animal health awareness, regulatory compliance requirements, and modernization of diagnostic infrastructure.
Rest Of Europe faces challenges including fragmented laboratory networks, varying regulatory standards across nations, cost pressures, and the need for infrastructure investment in smaller markets.
This study extensively used both primary and secondary sources. The research involved studying various factors affecting the industry to identify segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies.
This research study utilized comprehensive secondary sources, including directories, databases such as Bloomberg Business, Factiva, and Dun & Bradstreet, white papers, annual reports, company house documents, investor presentations, and SEC filings of companies. Secondary research was employed to identify and collect information relevant to an in-depth, technical, market-oriented, and commercial study of the infusion pump market. It was also used to identify key players in the market and classify and segment the industry based on trends to the most detailed level. Additionally, significant developments related to market and technology perspectives were noted. A database of the primary industry leaders was also created using secondary research.
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources from the supply side include project/sales/marketing/business development managers, presidents, CEOs, vice presidents, chairpersons, chief operating officers, chief strategy officers, directors, chief information officers, and chief medical information officers related to the veterinary reference laboratory. Primary sources from the demand side include healthcare professionals from veterinary hospitals, veterinary clinics, and veterinary diagnostic centers.
A breakdown of the primary respondents is provided below:
Note 1: C-level executives include CEOs, COOs, CTOs, and VPs.
Note 2: Other designations include sales, marketing, and product managers.
Note 3: Tiers are defined based on a company’s total revenue. As of 2024: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = < USD 500 million.
To know about the assumptions considered for the study, download the pdf brochure
The total size of the veterinary reference laboratory was determined after data triangulation from three approaches, as mentioned below. After each approach, the weighted average of the three approaches was taken based on the level of assumptions used in each approach.

After arriving at the market size, the total market was divided into several segments and subsegments. Data triangulation and market breakdown procedures were employed wherever applicable to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.
Veterinary reference laboratories refer to specialized diagnostic facilities that perform routine and advanced testing services for the detection, confirmation, and monitoring of animal diseases and disorders. These laboratories utilize a wide range of diagnostic methodologies, including clinical chemistry, hematology, immunodiagnostics, molecular diagnostics, urinalysis, microbiology, histopathology, toxicology, productivity testing, and pregnancy testing, to support evidence-based veterinary care. The market covers laboratory-based diagnostic services provided for companion and livestock animals by veterinary clinics and hospitals, research institutes, universities, point-of-care/in-house labs, government and public health agencies, and other end users. This report studies the market for such diagnostic services offered by reference laboratories while excluding laboratory software, imaging systems, and biopsy/necropsy services.
Full forecast, segment splits, and company analysis for all Veterinary Reference Laboratory Market.
Customize this report to your needs
Get 10% FREE Customization
Customize This Report